MELBOURNE, Australia and BRUSSELS, Belgium, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and SCK CEN (the Belgian Nuclear Research Centre) today announce that the first of two cyclotrons has been removed from the Company’s licensed radiopharmaceutical production facility in Brus Read more...
